Genetic polymorphism of the type A human natriuretic peptide receptor (NPR‐A) gene contributes to the interindividual variability in the BNP system

[1]  Mark A Miller,et al.  Oral Human Brain Natriuretic Peptide Activates Cyclic Guanosine 3,5-Monophosphate and Decreases Mean Arterial Pressure , 2005, Circulation.

[2]  C. Hamm,et al.  Relation of N-terminal pro B-type natriuretic peptide to progression of aortic valve disease. , 2005, European heart journal.

[3]  L. Køber,et al.  N-terminal pro-B-type natriuretic peptide and long-term mortality in stable coronary heart disease. , 2005, The New England journal of medicine.

[4]  H. White,et al.  N-Terminal Pro–B-Type Natriuretic Peptide Levels for Dynamic Risk Stratification of Patients With Acute Coronary Syndromes , 2004, Circulation.

[5]  C. Hamm,et al.  Relation of N-terminal pro-B-type natriuretic peptide to severity of valvular aortic stenosis. , 2004, The American journal of cardiology.

[6]  G. Baxter,et al.  Autocrine and paracrine actions of natriuretic peptides in the heart. , 2004, Pharmacology & therapeutics.

[7]  I. Squire,et al.  Reference ranges for natriuretic peptides for diagnostic use are dependent on age, gender and heart rate , 2003, European journal of heart failure.

[8]  A. Wu,et al.  Biological variation for N-terminal pro- and B-type natriuretic peptides and implications for therapeutic monitoring of patients with congestive heart failure. , 2003, The American journal of cardiology.

[9]  T. Izumi,et al.  Cyclic GMP production by ANP, BNP, and NO during worsening and improvement of chronic heart failure. , 2003, Japanese heart journal.

[10]  Michael D. Schneider,et al.  Pressure-independent cardiac hypertrophy in mice with cardiomyocyte-restricted inactivation of the atrial natriuretic peptide receptor guanylyl cyclase-A. , 2003, The Journal of clinical investigation.

[11]  H. Büller,et al.  Brain Natriuretic Peptide as a Predictor of Adverse Outcome in Patients With Pulmonary Embolism , 2003, Circulation.

[12]  L. Fisher,et al.  Changes in Brain Natriuretic Peptide and Norepinephrine Over Time and Mortality and Morbidity in the Valsartan Heart Failure Trial (Val-HeFT) , 2003, Circulation.

[13]  J. Parner,et al.  NT-proBNP: a new diagnostic screening tool to differentiate between patients with normal and reduced left ventricular systolic function , 2003, Heart.

[14]  S. Gottlieb,et al.  A rapid B-type natriuretic peptide assay accurately diagnoses left ventricular dysfunction and heart failure: a multicenter evaluation. , 2002, American heart journal.

[15]  Douglas W Mahoney,et al.  Plasma brain natriuretic peptide concentration: impact of age and gender. , 2002, Journal of the American College of Cardiology.

[16]  D. Levy,et al.  Impact of age and sex on plasma natriuretic peptide levels in healthy adults. , 2002, The American journal of cardiology.

[17]  Mostafa Ronaghi,et al.  Pyrosequencing™: An accurate detection platform for single nucleotide polymorphisms , 2002, Human mutation.

[18]  M. Sabatine,et al.  The prognostic value of B-type natriuretic peptide in patients with acute coronary syndromes. , 2001, The New England journal of medicine.

[19]  T. Nakayama,et al.  Functional deletion mutation of the 5'-flanking region of type A human natriuretic peptide receptor gene and its association with essential hypertension and left ventricular hypertrophy in the Japanese. , 2000, Circulation research.

[20]  M. Uhlén,et al.  Single-nucleotide polymorphism analysis by pyrosequencing. , 2000, Analytical biochemistry.

[21]  M. Kinoshita,et al.  Plasma brain natriuretic peptide level as a biochemical marker of morbidity and mortality in patients with asymptomatic or minimally symptomatic left ventricular dysfunction. Comparison with plasma angiotensin II and endothelin-1. , 1999, European heart journal.

[22]  H. S. Kim,et al.  Hypertension, cardiac hypertrophy, and sudden death in mice lacking natriuretic peptide receptor A. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[23]  H. Hense,et al.  Evaluation of plasma natriuretic peptides as markers for left ventricular dysfunction. , 1997, American heart journal.

[24]  H. Itoh,et al.  Plasma levels of brain and atrial natriuretic peptides elevate in proportion to left ventricular end-systolic wall stress in patients with aortic stenosis. , 1997, American heart journal.

[25]  D. Schocken,et al.  Negative feedback of atrial natriuretic peptides. , 1994, The Journal of clinical endocrinology and metabolism.

[26]  K. Inouye,et al.  Brain natriuretic peptide as a novel cardiac hormone in humans. Evidence for an exquisite dual natriuretic peptide system, atrial natriuretic peptide and brain natriuretic peptide. , 1991, The Journal of clinical investigation.

[27]  J. Knowles,et al.  Common variations in noncoding regions of the human natriuretic peptide receptor A gene have quantitative effects , 2002, Human Genetics.